Physician profile
Jay Stephen Webb
NPI 1821483140
$7,170.85
in general payments reported to CMS, 2019-2025
8 companies · $1,123 in 2025
The $1,123 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,427 · 2022: $1,409 · 2023: $1,106 · 2024: $1,106 · 2025: $1,123.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,335.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,995.54 | 2021-2025 | Embold Fibered, Therasphere Y90 Glass Microspheres 10 Gbq, General - Cryoplasty |
| Penumbra, INC. | $2,615.46 | 2021-2025 | Ruby Coil, Indigo System, Penumbra System |
| Medtronic, INC. | $694.72 | 2023-2024 | In.Pact Av, Mvp, Concertotm |
| Trisalus Life Sciences, INC. | $221.48 | 2024-2025 | Trinav Infusion System |
| Siemens Medical Solutions USA, INC. | $182.28 | 2022 | |
| Canon Medical Systems USA, INC. | $181.55 | 2022 | |
| Philips North America LLC | $151.45 | 2022 | |
| Cardiovascular Systems INC. | $128.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Webb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.